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Introduction
Chronic wasting disease (CWD) is a transmissible spongi-
form encephalopathy of cervid species with naturally occur-
ring infections identified in Canada and the United States 
in white-tailed deer (Odocoileus virginianus), mule deer 
(Odocoileus hemionus), Rocky Mountain elk (Cervus elaphus 
nelsoni), and moose (Alces alces shirasi).1,18,19 Like other 
transmissible spongiform encephalopathies, CWD has a long 
incubation period lasting months to years, eventually leading 
to the accumulation of abnormal protease resistant prion pro-
tein (PrPCWD) in the brain, resulting in neurologic disease and 
death.18
Chronic wasting disease was first identified in Colorado 
and has since been found in both domestic and wild cervids 
in expanding regions of North America.18,19 Chronic wasting 
disease has been identified in the provinces of Saskatchewan 
and Alberta in Canada and in 19 states across the United 
States (http://www.nwhc.usgs.gov/disease_information/chronic 
_wasting_disease/). Control of the disease has been hampered 
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Diagnostic accuracy of rectal mucosa  
biopsy testing for chronic wasting disease 
within white-tailed deer (Odocoileus 
virginianus) herds in North America: 
Effects of age, sex, polymorphism at 
PRNP codon 96, and disease progression
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James McLane, Robert W. Allen, Alex A. McIsaac, Gordon B. Mitchell, Delwyn P. Keane, 
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Abstract. An effective live animal diagnostic test is needed to assist in the control of chronic wasting disease (CWD), 
which has spread through captive and wild herds of white-tailed deer (Odocoileus virginianus) in Canada and the United 
States. In the present study, the diagnostic accuracy of rectal mucosa biopsy sample testing was determined in white-tailed 
deer from 4 CWD-infected captive herds. Specifically, the current study compared the immunohistochemical detection of 
disease-associated prion protein in postmortem rectal mucosa biopsy samples to the CWD status of each deer as determined 
by immunodiagnostic evaluations of the brainstem at the obex, the medial retropharyngeal lymph node, and the palatine tonsil. 
The effects of age, sex, genotype, and disease progression were also evaluated. Diagnostic sensitivity on rectal biopsy samples 
for CWD in white-tailed deer ranged from 63% to 100%; the pooled estimate of sensitivity was 68% with 95% confidence 
limits (95% CLs) of 49% and 82%. However, diagnostic sensitivity was dependent on genotype at prion protein gene (PRNP) 
codon 96 and on disease progression as assessed by obex grade. Diagnostic sensitivity was 76% (95% CLs: 49%, 91%) for 
96GG deer but only 42% (95% CLs: 13%, 79%) for 96GS deer. Furthermore, diagnostic sensitivity was only 36% for deer 
in the earliest stage of disease (obex grade 0) but was 100% for deer in the last 2 stages of preclinical disease (obex grades 3 
and 4). The overall diagnostic specificity was 99.8%. Selective use of antemortem rectal biopsy sample testing would provide 
valuable information during disease investigations of CWD-suspect deer herds.
Key words: Chronic wasting disease; rectal mucosa biopsy; white-tailed deer.
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by the lack of a highly sensitive and specific antemortem 
diagnostic test method.13 Current methods in Canada and the 
United States utilize brain stem, medial retropharyngeal 
lymph node, and palatine tonsil samples collected postmor-
tem, which are then tested by immunohistochemistry (IHC), 
enzyme-linked immunosorbent assay (ELISA), and/or 
Western blot (WB) to detect PrPCWD. In white-tailed deer, 
PrPCWD accumulates within multiple lymphoid tissues such 
as lymph nodes, tonsil, and gut-associated lymphoid tissue 
during the subclinical phase of disease, prior to the accumu-
lation of PrPCWD within the brain.7,8 Protease-resistant prion 
protein in white-tailed deer has a similar tissue distribution 
to scrapie within sheep and goats, and this wide tissue distri-
bution of abnormal prion protein has been exploited by the 
utilization of antemortem rectal biopsy testing for the control 
and eradication of scrapie in Canada since 2006 and in the 
United States since 2008.3–5 Scrapie diagnostic testing on 
rectal biopsy samples by the U.S. Department of Agriculture 
(USDA) is used in specific types of epidemiologic investiga-
tions and has been found to be a safe and effective method in 
live animals.3 In white-tailed deer, biopsy samples from pal-
atine tonsil and rectal mucosa have both shown promise as 
possible antemortem methods to detect CWD.7,17,20 The rec-
tal biopsy procedure has the advantages of being a simpler 
and more rapid procedure that can often be performed with-
out sedation.7
The purpose of the current study was to determine the 
CWD diagnostic accuracy of immunohistochemical detec-
tion of PrPCWD in rectal biopsy samples of white-tailed deer 
from known positive herds. Through a cooperative effort 
between the Canadian Food Inspection Agency (CFIA) and 
the USDA, rectal biopsy and other tissue samples were col-
lected from white-tailed deer in 4 herds, each herd depopu-
lated because of a previous diagnosis of CWD. All tissue 
samples were collected postmortem. Detection of PrPCWD in 
rectal biopsy samples was compared to the CWD infection 
status of each animal as determined by the official test meth-
ods of each country utilizing samples of the brainstem, retro-
pharyngeal lymph node, and tonsil. All rectal biopsy samples 
were tested by IHC at a single laboratory. In addition, the 
effect of age, sex, genotype at prion protein gene (PRNP) 
codon 96, and stage of disease progression on the diagnostic 
accuracy of rectal mucosa biopsy testing was examined.
Materials and methods
Study populations
The white-tailed deer captive herds in the present study 
included 3 herds in Canada (Canada herds 1–3) and 1 herd in 
the United States (U.S. herd 1). For the purposes of the 
investigation, the study populations consisted of the deer 
euthanized during depopulation of each farm. At the time of 
depopulation, clinical signs of CWD were not evident in 
any deer from these herds. Canada herd 1 was a 65-hectare 
breeding operation established in northeastern Saskatchewan 
during the spring of 2005. Chronic wasting disease was first 
diagnosed in 2 deer that were found dead in September 2007 
and tested as part of a mandatory CWD surveillance pro-
gram. There were 122 adult deer and fawns tested for CWD 
in the facility at the time of depopulation in December 2007. 
Canada herd 2 was a 57-hectare breeding and hunting opera-
tion located in northwestern Saskatchewan. Chronic wasting 
disease was first diagnosed in 3 does that were slaughtered 
and then tested as part of a mandatory CWD surveillance 
program in January 2008. There were 385 deer (excluding 
deer < 12 months of age, which are not routinely tested for 
CWD as part of CFIA depopulation protocols) depopulated 
and tested for CWD at the facility in May 2008. Canada 
herd 3 was a 16-hectare breeding operation in northeastern 
Saskatchewan. Epidemiologic investigations had determined 
that this herd was the herd of origin of 2, previously identi-
fied, CWD-infected deer. The herd was confirmed to be infected 
in January 2011, and 48 deer (excluding deer < 12 months of 
age) were depopulated and tested for CWD in February 
2011. U.S. herd 1 was a 72-hectare hunting operation in 
Wisconsin in which CWD was first diagnosed on the farm in 
an adult doe in the fall of 2008 as part of a voluntary CWD 
surveillance program. In the winter of 2008, at the time of 
the study and herd depopulation, the herd was composed of 
66 adult deer and fawns.
Sample collection
After euthanasia, the sex and age of each deer was deter-
mined. The age of the deer was determined either by herd 
records or was estimated by visual inspection of the teeth. 
Brainstem at the obex, medial retropharyngeal lymph node, 
and/or tonsil and rectal mucosa biopsy samples were col-
lected for CWD testing. More specifically, an approximately 
round, 2 cm in diameter portion of rectal mucosa immedi-
ately cranial to the anal mucocutaneous junction was sam-
pled and then placed mucosal side down, within a 
sponge-lined histology cassette.
Testing of rectal biopsy samples
Testing of the formalin-fixed rectal mucosa biopsy samples 
from all 4 herds was performed at the USDA National 
Veterinary Services Laboratories (Ames, Iowa) following a 
previously described procedure.3 Briefly, after routine tissue 
processing, the biopsy samples were embedded in paraffin 
(with the mucosal surface facing, and parallel to, the front sur-
face of the block). A 5-μm section was obtained at a depth of 
approximately 250 μm and a second section at a depth of 
approximately 350 μm from the surface of the mucosa. 
Immunohistochemical testing was performed following the 
USDA CWD test protocol with an automated immunostainera 
using the mouse monoclonal 99/97.6.1 anti–prion protein 
antibodyb as the primary antibody.14 Positive control tissues, 
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consisting of scrapie-positive brain and lymph node, were 
included with each staining run. Tissues were considered posi-
tive if there was immunohistochemical staining of the appro-
priate character and location in the tissue (Fig. 1).3,18 Tissues 
were considered negative if immunohistochemical staining of 
the appropriate character and location in the tissue was not 
detected in the tissue. Any lymphoid tissue samples, including 
rectal biopsy samples that contained less than 6 lymph folli-
cles in the entire sample, were considered inadequate to make 
a negative test result determination. No minimum number of 
lymphoid follicles was required to make a positive determina-
tion. Pathologists interpreting the rectal biopsy samples were 
blinded to test results from other tissues.
Testing of obex, lymph node, and tonsil samples
Obex, lymph node, and palatine tonsil samples from U.S. 
herd 1 were tested by the immunohistochemical procedure as 
described previously for the rectal biopsy samples. Testing 
of the obex, lymph node, and palatine tonsil samples from 
Canada herds 1–3 was carried out by IHC, ELISA, and/or 
WB and included positive and negative controls on each 
assay. All 3 methods were applied to obex, lymph node, and 
palatine tonsil samples from Canada herd 1. At the time of 
testing samples, from Canada herds 2 and 3, the ELISA 
method was being used to first screen all 3 tissues, after 
which a concordant IHC or WB result was used to confirm 
all positive samples. The methods have been previously 
described for IHC using a mouse monoclonal 99/97.6.1 anti–
prion protein antibodyc as the primary antibody with an auto-
mated immunostainer.a,2,14 Immunodetection by ELISAd 
and WBe was performed on unfixed tissue samples using 
commercial test kits according to the manufacturer’s instruc-
tions and as previously described.2,6 The ELISA absorbance 
cut-off value for PrPCWD detection was calculated by adding 
a fixed value of 0.09 to the mean optical density of the nega-
tive controls.6 The WB protein bands were evaluated using a 
digital imaging system and analysis software.f
Grading of obex samples as an  
estimate of disease progression
Chronic wasting disease progression was estimated using 
IHC in each deer that was positive on brain tissue by each 
country’s initial screening test (ELISA testing for Canada 
herds 1–3) and IHC testing for U.S. herd 1. Obex grading 
was performed similarly to previously described methods.12 
Obex grades were assigned based on the following criteria: 
grade 0, no IHC PrPCWD staining present in the obex or 
ELISA negative on fresh obex samples; grade 1, minimal 
IHC PrPCWD staining primarily restricted to the ventral area 
of the dorsal motor nucleus of the vagus (DMNV); grade 2, 
moderate IHC PrPCWD staining in the DMNV and the nucleus 
of the solitary tract; grade 3, heavy IHC PrPCWD staining 
present in the DMNV with lighter staining that extended to 
other adjacent nuclei (including the nucleus of the solitary 
tract) and white matter; grade 4, IHC PrPCWD staining pres-
ent in the DMNV, adjacent nuclei, and white matter.
Determination of codon 96 polymorphism
Two methods were used for the determination of the codon 
96 polymorphism. For Canada herds 1 and 2 and U.S. herd 1, 
DNA was extracted from archived fixed or frozen tissue. The 
open reading frame of the PRNP gene was amplified and 
sequenced as described using primers specific for the cervid 
functional gene and excluding amplification of the cervid 
processed pseudogene.10 For Canada herd 3, genomic DNA 
samples were isolated and purified from the ethylenediamine 
tetra-acetic acid–anticoagulated blood or homogenized 
brain tissue using an automated DNA extractor. Real-time 
polymerase chain reaction (PCR) assays were performed 
using primers (5’-AGCCACATGGTGGTGGAG-3’; 5’-TG 
GTTTACTGGGCTTGTTCC-3’) and allelic-specific probes 
(FAM-TCAAGGTGGTACCCAC–MGBNFQ; VIC-TCAA 
AGTGGTACCCACAG–MGBNFQ).g,h The genotype was 
determined based on the baseline threshold and threshold 
cycle (Ct) generated by detection software and using positive 
control samples to discriminate the GG, GS, and SS alleles.
Statistical methods
Data sets were recorded in spreadsheetsi and imported into 
SASj for data handling, summary and analyses, and graph 
production. Within each herd, one-way table analysis (the 
Frequency procedure, SAS) was used to compute the exact 
Figure 1. Rectal mucosa; white-tailed deer (Odocoileus virgin-
ianus). A prominent lymphoid follicle in the lamina propria con-
tains abundant immunohistochemical staining for protease resistant 
prion protein (PrPCWD). Streptavidin–alkaline phosphatase immu-
nohistochemistry using an anti-prion antibody and hematoxylin 
counterstain. Bar = 100 μm.
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binomial and 95% confidence intervals of intraherd prevalence 
of CWD. Stepwise selection and exact conditional logistic 
analyses (the Logistic procedure, SAS) were used to deter-
mine the effects of deer factors (age, sex, and PRNP codon 
96) on the probability of a positive CWD infection status. 
The model used reference cell coding and lenient P values 
for model entry (0.5) and elimination (0.1). Exact odds ratios 
with 95% upper and lower confidence limits (95% CLs) con-
ditioned by all significant explanatory factors were subse-
quently determined. Association between disease progression 
(estimated by obex grade) and PRNP genotype at codon 
96 was determined by requesting Somers D statistics (the 
Frequency procedure, SAS) for all study herd deer with a 
positive CWD infection status and complete data set.
The diagnostic accuracy (sensitivity and specificity) for 
determining CWD infection status of white-tailed deer by 
rectal biopsy testing was determined per herd using the 
Frequency procedure (SAS) as implemented in SAS Usage 
Note 24170 (http://support.sas.com/kb/24/170.html). The 
Surveyselect procedure (SAS) was used to randomly select 1 
diagnostic result per deer in Canada herds 2 and 3 in which 2 
diagnostic rectal mucosa biopsy samples had been collected 
but assigned discordant outcomes. Random selections were 
made within herd strata defined by disease status, age group, 
and codon 96 in order to avoid inadvertent introduction of 
selection bias. A meta-analytic bivariate approach was used 
to compute pooled estimates of diagnostic sensitivity and 
specificity.11 The generalized linear random-effects model 
(random subject effect, herd ID; the GLIMMIX procedure, 
SAS) was based on code provided previously.9 The meta-
analytic pooled estimates were first computed using only the 
herds of the current study (n = 4) and then inclusive of data 
from 2 additional herds (n = 6 total) from a similarly con-
ducted U.S. study.7 Unless otherwise stated, all meta-analy-
ses converged with satisfaction of the convergence 
criterion.
Results
Case herds summary statistics
Deer herd populations, PRNP genotype at codon 96, sex, 
age, and CWD infection status are summarized in Table 1. 
Canada herd 1 was composed of 122 deer, which were 
depopulated in December 2007, 38 (31%) of which were 
determined to be CWD positive by testing of obex, lymph 
node, and/or palatine tonsil samples. Eleven (9%) of these 
deer had rectal biopsy samples with an insufficient number 
of lymphoid follicles and were excluded from the rectal 
biopsy statistical analyses. Canada herd 2 contained 385 deer 
when the facility was depopulated in May 2008, 79 (21%) of 
which were determined to be CWD positive based on testing 
of obex, lymph node, or palatine tonsil. Forty-seven (12%) 
of these deer had rectal biopsy samples with an insufficient 
number of lymphoid follicles and were excluded from the 
rectal biopsy statistical analyses. Deer from the breeding 
facility ranged from 1 to 12 years of age, but for 210 (55%) 
of these deer, age was recorded only as “M” for mature 
(4–8 years old) and were thus excluded from further analyses 
that included age as a continuous covariate. Thirty-two 
(67%) of the 48 deer in Canada herd 3 at the time of depopu-
lation were determined to be CWD positive. Twenty-one 
(44%) of these deer had rectal biopsy samples with an insuf-
ficient number of lymphoid follicles and were excluded from 
the rectal biopsy statistical analyses. U.S. herd 1 contained 
66 deer at the time of depopulation of which only a single 
deer (approximately 2%) was determined to be CWD posi-
tive. Eleven (17%) of these deer had rectal biopsy samples 
with an insufficient number of lymphoid follicles and were 
excluded from the rectal biopsy statistical analyses.
Effects of age, sex, and genotype at PRNP codon 96 
on likelihood of a positive CWD infection status
The potential influence of age, sex, and genotype at PRNP 
codon 96 on the likelihood of a positive CWD infection sta-
tus at the time of depopulation was investigated. Having 
only 1 positive case, U.S. herd 1was excluded from this anal-
ysis. A significant dependence on age or sex at the time of 
depopulation was not detected for deer in any of the Canadian 
herds. A positive CWD infection status was significantly 
dependent on codon 96 for deer from Canada herds 1 and 3 
but this factor did not reach statistical significance for deer 
from Canada herd 2 (Table 2). From the exact conditional 
logistic analysis, odds ratios relative to 96GG deer were sig-
nificant for both 96GS deer and 96SS deer such that 96GS 
deer were overall approximately 3 times less likely, and 
96SS deer approximately 19 times less likely, than 96GG 
deer to be CWD positive at the time of depopulation.
Diagnostic accuracy of postmortem  
rectal biopsy testing
The diagnostic sensitivity of postmortem rectal biopsy test-
ing for determination of CWD infection status is summa-
rized in Figure 2 as a forest plot accompanied by summary 
data for each herd. The diagnostic sensitivity for individual 
herd investigations varied from 63% to 100%. The pooled 
estimate of diagnostic sensitivity (Fig. 2) for the herds 
of this study (n = 4 herds) was 68% with 95% CLs of 49% 
and 82%.
Regarding diagnostic specificity of postmortem rectal 
biopsy sample testing for determination of CWD infection 
status in white-tailed deer, only 1 sample was scored as posi-
tive in an animal in which PrPCWD was not detected (in this 
context referred to as a “false-positive”; Fig. 2). Thus, esti-
mates of diagnostic specificity under these conditions ranged 
from 99.6% in Canada herd 2 to 100% in all other study 
herds. The pooled estimate of specificity was 99.8% (n = 4 
herds, 95% CLs: 84.1%, 100.0%). Given the near uniform 
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accuracy of postmortem rectal biopsy testing with regard to 
diagnostic specificity, further investigations were limited to 
testing for the effects of deer factors on rectal biopsy sample 
diagnostic sensitivity.
Effects of age, sex, genotype at PRNP codon 96, 
and stage of disease progression on diagnostic 
sensitivity
Considering the significant effects of PRNP codon 96 poly-
morphism on the temporal patterns of PrPCWD detection in 
rectal biopsy samples of deer and, in the present study, on the 
likelihood of a positive CWD infection status, the effect 
of genotype at codon 96 on rectal biopsy sample diagnostic 
Table 1. White-tailed deer (Odocoileus virginianus) herd characteristics for chronic wasting disease (CWD) prevalence with 95% 
confidence limits (95% CLs), PRNP genotype at codon 96, sex, and age.
Age (years) by CWD infection status¦
(min.–[median]–max.) [frequency]
Study 
population
Total no. of 
deer
CWD prevalence* 
(95% CL)†
PRNP at codon 96‡ 
[frequency] Sex§ [frequency] CWD+ CWD–
Canadian herd 1 122 31.15 (23.07, 40.16) GG [84 (68.85%)] F [42 (34.43%)] 0.58–[1.58]–5.58
[19 (15.57%)]
0.50–[1.58]–4.58
[23 (18.85%)]
 M [41 (33.61%)] 0.58–[2.08]–3.58
[14 (11.48%)]
0.5–[1.58]–7.58
[27 (22.13%)]
 Na [1 (0.82%)] 2.58
[1 (0.82%)]
 GS [36 (29.51%)] F [21 (17.21%)] 0.50–[2.58]–2.58
[3 (2.46%)]
0.58–[2.08]–7.58
[18 (14.75)]
 M [15 (12.30%)] 4.58–7.58
[2 (1.64%)]
0.58–[2.58]–4.58
[13 (10.66%)]
 NA [2 (1.64%)] F [2 (1.64%)] 1.58–1.58
[2 (1.64%)]
Canadian herd 2 385 20.52 (16.60, 24.90) GG [347 (90.13%)] F [175 (45.45%)] [33 (8.57%)] [142 (36.88%)]
 M [172 (44.68%)] [43 (11.17%)] [129 (33.51%)]
 GS [19 (4.94%)] F [10 (2.60%)] [10 (2.60%)]
 M [9 (2.34%)] [3 (0.78%)] [6 (1.56%)]
 NA [19 (4.94%)] F [6 (1.56%)] [6 (1.56%)]
 M [13 (3.38%)] [13 (3.38%)]
Canadian herd 3 48 66.67 (51.59, 79.60) GG [10 (20.83%)] F [9 (18.75%)] 2–[4]–9
[8 (16.67%)]
3
[1 (2.08%)]
 M [1 (2.08%)] 4
[1 (2.08%)]
 
 GS [30 (62.50%)] F [30 (62.50%)] 2–[4]–11
[21 (43.75%)#]
3–[7]–11
[9 (18.75%)]
 SS [8 (16.67%)] F [8 (16.67%)] 6–9
[2 (4.17%)]
2–[3]–5
[6 (12.50%)]
U.S. herd 1 66 1.52 (0.04, 8.16) GG [49 (74.24%)] F [26 (39.39%)] [1 (1.52%)] [25 (37.88%)]
 M [23 (34.85%)] [23 (34.85%)]
 GS [17 (25.76%)] F [12 (18.18%)] [12 (18.18%)]
 M [5 (7.58%)] [5 (7.58%)]
* The intraherd binomial proportion expressed here as the percentage positive.
† Exact 95% confidence limits (95% CLs) for the intraherd binomial proportion of CWD status = positive.
‡ PRNP codon 96 genotype given as the deduced amino acids: G = glycine; S = serine; NA = information not available.
§ F = female; M = male.
¦ Detection of PrPCWD by immunoassay: + = positive; – = negative.
# Includes 2 animals with missing age data; median based on 19 animals.
Table 2. Effect of genotype at PRNP codon 96 on the 
likelihood of a positive chronic wasting disease infection status in 
Canada herds of white-tailed deer.*
Population
Exact odds ratios 
(vs. 96GG) LCL, UCL P value
Canada herd 1 96GS: 0.252 0.069, 0.746 0.0088
Canada herd 2 96GS: 0.669 0.122, 2.427 0.7663
Canada herd 3 96GS: 0.267 0.005, 2.476 0.4085
 96SS: 0.048 <0.001, 0.688 0.0181
Overall estimates 96GS: 0.338 0.137, 0.748 0.0048
 96SS: 0.052 0.004, 0.402 0.0021
* U.S. herd 1 was excluded from this analysis because the herd contained 
only a single chronic wasting disease–positive deer. LCL, UCL = 95% 
lower and upper confidence limits, respectively.
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sensitivity was examined.20 For individual herds, exact esti-
mates of diagnostic sensitivities ranged from 67% to 100% in 
96GG deer and from 0% to 60% in 96GS deer (Fig. 3). Only 
8 96SS deer were identified in the current study, 2 of which 
were determined to be CWD positive (Table 1). PrPCWD was 
not detected in the rectal biopsy samples from either of the 2 
CWD-positive 96SS deer. The pooled estimates of rectal 
biopsy sample diagnostic sensitivity by genotype at codon 96 
were 76% (95% CLs: 49%, 91%) for 96GG deer and 42% 
(95% CLs: 13%, 79%) for 96GS deer; a pooled estimate for 
96SS deer was not made given the number of cases.
All deer in the present study had unknown sources and 
timing of exposure and were deemed to be nonclinical at 
the time of depopulation. Thus, brainstem accumulation of 
Figure 2. Rectal biopsy sample diagnostic sensitivity for chronic wasting disease in preclinical North American white-tailed deer 
(Odocoileus virginianus). A forest plot is shown to aid comparison of test sensitivities between herds (squares) and the pooled estimate 
(diamond). To the right of each plot is given the exact measures of sensitivity (sens), lower and upper 95% confidence limits (LCL, UCL), 
and the frequencies of rectal biopsy test results categorized relative to gold standard testing. TP = true-positive; FP = false-positive; FN = 
false-negative; TN = true-negative.
Figure 3. Rectal biopsy sample diagnostic sensitivity for chronic wasting disease in preclinical North American white-tailed deer 
(Odocoileus virginianus) characterized by PRNP codon 96 genotype. A forest plot is shown to aid comparison of test sensitivities between 
herds (squares) and the pooled estimates (diamonds). To the right of each plot is given the exact measures of sensitivity (sens), lower and 
upper 95% confidence limits (LCL, UCL), and the frequencies of rectal biopsy test results categorized relative to gold standard testing. TP = 
true-positive; FP = false-positive; FN = false-negative; TN = true-negative.
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PrPCWD at the level of the obex (obex grade, where 0 = not 
detected and 4 = maximum accumulation) was used as a sur-
rogate indicator of disease progression in CWD-positive 
deer. As seen in Figure 4, there was a clear association of 
early disease progression (low obex grades) with lower esti-
mates of rectal biopsy sample diagnostic sensitivity. Given 
smaller numbers of CWD-positive deer within each obex 
grade subgroup, the measures of sensitivity were somewhat 
variable between herds. Nevertheless, the modeled effect of 
obex grade on rectal biopsy sample diagnostic sensitivity 
was significant in the meta-analysis of the study herds 
(P = 0.0230). The pooled estimates of sensitivity were 36% 
for obex grade 0 deer, 83% for obex grade 1 deer, 93% for 
obex grade 2 deer, and 100% for deer with obex grades 3 or 4.
To test the hypothesis that reduced rectal biopsy sample 
diagnostic sensitivity in white-tailed deer with G96S poly-
morphism might be associated with slower disease progres-
sion, the association of obex grade with genotype at codon 
Figure 4. Rectal biopsy sample diagnostic sensitivity for chronic wasting disease (CWD) in preclinical North American white-tailed 
deer (Odocoileus virginianus) characterized by brainstem accumulation of protease resistant prion protein (PrPCWD) at the level of the obex 
(obex grade). Obex grade (OG) ranged from 0 (PrPCWD not detected) to 4 (maximum accumulation). A forest plot is shown to aid comparison 
of test sensitivities between herds (squares) and the pooled estimates (diamonds). To the right of each plot is given the exact measures of 
sensitivity (sens), lower and upper 95% confidence limits (LCL, UCL), and the frequencies of rectal biopsy test results categorized relative 
to gold standard testing. TP = true-positive; FP = false-positive; FN = false-negative; TN = true-negative).
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96 in deer with a positive CWD infection status at the time of 
depopulation was measured. As shown in Figure 5, the pro-
portion of deer in later stages of disease progression (obex 
grades > 0) decreased with G96S polymorphism, though this 
association did not reach statistical significance (Somers D = 
–0.2066, 95% CLs: –0.4188, 0.0057; P = 0.0645). When 
similarly stratified by stage of disease progression, G96S 
polymorphism also appears to be negatively associated with 
the proportion of positive lymph follicles per rectal biopsy 
sample of CWD-positive white-tailed deer (Fig. 6).
Discussion
A safe and effective live animal diagnostic test is needed to 
assist in the control of CWD, which currently relies on test-
ing of samples collected only after the death of the deer. 
Identification of CWD-infected herds is further hindered 
because the disease has a long subclinical period.18 The cur-
rent study included over 600 clinically normal white-tailed 
deer, in 4 genetically and geographically diverse herds, and 
showed that rectal biopsy sample testing was an effective 
method in detecting subclinical CWD infection. The diag-
nostic sensitivity of rectal biopsy testing for determining 
CWD infection status ranged from 63% to 100% in the 4 
white-tailed deer herds in the study. The aim of the meta-
analytic modeling in the present study was to improve the 
estimate of diagnostic sensitivity accuracy in a manner more 
broadly applicable to future application.9,11 Thus, the pooled 
estimate of diagnostic test sensitivity of rectal biopsy testing 
was 68% when based on the 4 herds of the current study, 
which was refined to 74% (95% CLs: 60% and 85%) after 
inclusion of data from 2 additional herds from a similarly 
conducted study (data not shown).7 Conversely, false-nega-
tive results should be expected from rectal biopsy samples in 
generally one-fourth of all CWD-infected deer. Thus, a neg-
ative test result based on a single rectal biopsy sample should 
not be interpreted as a deer being free of CWD infection.
Figure 5. The proportional brainstem accumulation of protease resistant prion protein (PrPCWD) at the level of the obex (obex grade) in 
North American white-tailed deer (Odocoileus virginianus) with preclinical chronic wasting disease (CWD) grouped by genotype at PRNP 
codon 96. Note the decreased proportion of deer with G96S polymorphism that have grade 1 or greater accumulation of PrPCWD. Data 
represent the pooled records of deer for which obex grades (scale: 0, PrPCWD not detected; 4, maximum accumulation) and genotypes were 
available (Canada herds 1, 2, and 3 representing 119 GG, 29 GS, and 2 SS deer).
Figure 6. The proportion of protease resistant prion protein 
(PrPCWD)-positive rectal mucosal lymphoid follicles in North 
American white-tailed deer (Odocoileus virginianus) with preclinical 
chronic wasting disease (CWD) and grouped by genotype at PRNP 
codon 96 and disease progression. Disease progression estimated by 
brainstem accumulation of PrPCWD at the level of the obex (obex grade: 
0, PrPCWD not detected; 4, maximum accumulation). Shown are box 
plots depicting the interquartile range (gray box with limits of 25th 
and 75th percentiles), mean (diamond) and median (gray box center 
line), and data falling within (stems) and outside (open circles) the 1.5 
interquartile range. Data represent deer for which the proportion of 
positive rectal mucosal lymphoid follicles could be determined and 
for which obex grades and genotypes were available (Canada herds 1, 
2, and 3 representing 196 GG, 35 GS, and 2 SS deer).
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Rectal biopsy diagnostic testing of deer should be done 
concurrently with PRNP genotype testing in order to make a 
more accurate assessment of test results. In an experimental 
inoculation study of CWD in white-tail deer, PrPCWD was 
detected at earlier time periods postinoculation in tonsil and 
rectal mucosa in codon 96GG deer as compared to 96GS and 
96SS deer.20 As demonstrated in the present study, knowl-
edge of the genotype is important because rectal biopsy sam-
ple test sensitivity was 76% for 96GG deer, but dropped to 
42% for 96GS deer. Additionally and not surprisingly, the 
rectal biopsy test sensitivity was the greatest (100%) in deer 
with advanced disease as evidenced by abundant PrPCWD in 
the brain and the lowest (36%) in deer in which PrPCWD was 
not detected in brain tissue and only detected in lymph tis-
sues; thus in agreement with a previous study.7 Higher rates 
of false-negative rectal biopsy results are expected in white-
tailed deer in earlier stages of CWD disease progression and 
in deer having PRNP G96S polymorphism.
The diagnostic specificity of rectal biopsy sample testing for 
determining CWD infection status was 99.8% and not 100% 
for the 4 herds of the current study due to a single deer in 
Canada herd 2 classified as a false positive. The rectal biopsy 
from the 2-year-old, codon 96GG deer had a single positive 
lymphoid follicle out of 143 total follicles, and the positive 
staining was repeatable on serial tissue sections. Possible expla-
nations for these conflicting test results include ineffective sub-
sampling of the obex and lymph node samples, which may 
have had limited focal PrPCWD deposition and led to false-
negative obex and lymph node results. An abnormal PrPCWD 
tissue distribution pattern due to individual animal variation is 
another possibility. Other studies have identified deer in which 
the PrPCWD tissue distribution did not follow the expected pat-
tern of appearing in select lymph tissues before appearing in the 
brainstem (e.g., a white-tailed deer in which PrPCWD was found 
only within brain tissue and not within lymph node samples).8
The effect of genotype polymorphism at codon 96 was 
also examined because it has been shown to correlate with 
the CWD infection status of deer.8,10 Chronic wasting dis-
ease infection status based on brain, lymph node, and 
palatine tonsil testing was negatively associated with poly-
morphisms of codon 96, such that deer with G96S polymor-
phism were less likely than GG deer to be test-positive at the 
time of depopulation. Though this association with the het-
erozygous genotype (96GS) reached statistical significance 
only in Canada herd 1, the estimated odds ratios for this 
genotype in Canada herds 2 and 3 were of similar magnitude 
and direction. However, the effect of serine at codon 96 does 
not prevent CWD infection, as evidenced in the respective 
70% and 25% infection rates in 96GS and 96SS deer of 
Canada herd 3. Disease progression, as measured by obex 
grading, also appeared to be slower in 96GS and 96SS deer 
as compared to 96GG herd mates, a conclusion consistent 
with previous findings.7,8,20 There may be other unidentified 
polymorphisms of the prion gene that have additional influ-
ence on the pathogenesis of CWD.
Although the samples in the current study were collected 
postmortem, rectal biopsy testing for CWD and scrapie on 
live animals has been shown to be safe for the animal and 
relatively simple to perform by the surgeon.3,15 When per-
forming the rectal biopsy, care must be taken to identify the 
proper biopsy site in order to obtain a sample that contains 
lymphoid follicles. Lymphoid follicles are most abundant 
within an approximately 1 cm–wide band of mucosa and 
submucosa immediately cranial to the stratified squamous 
epithelium of the rectoanal junction; samples collected prox-
imal or distal to that location have fewer or no lymphoid 
follicles, which results in nondiagnostic samples.7 Fewer 
lymph follicles are also found within rectal biopsy samples 
collected from older animals.3,16 In the present study, the per-
centage of samples with an insufficient number of follicles 
occurred at an unexpectedly high rate (44%) in Canada herd 
3, while the other 3 herds had rates of 9–17%, which is simi-
lar to a previous study.7 Because the procedure causes mini-
mal discomfort to the animal, the procedure is often 
performed using only restraint in proper animal handling 
facilities and topical anesthesia.3,15 In contrast, the only other 
commonly used live animal CWD test used in research is the 
palatine tonsil biopsy.20 The palatine tonsil biopsy is a more 
complex procedure that carries potentially greater risk due to 
the necessity of sedation or general anesthesia, but has shown 
a greater sensitivity at detecting PrPCWD in the early stages of 
disease.7,20
The current study provides additional evidence that rectal 
biopsy samples can be used successfully to detect subclinical 
CWD infections in white-tailed deer. Polymorphisms of 
codon 96 and stage of disease progression have major effects 
on the expected level of diagnostic sensitivity, so any inter-
pretation of biopsy sample results in which PrPCWD is not 
detected should consider these 2 factors. Genotype testing 
can easily identify the codon 96 polymorphism of each deer. 
However, estimating the level of disease progression is much 
more difficult and often impossible, but could potentially be 
estimated based on the predicted date of exposure. One 
potential use for this test may be for epidemiologic investi-
gations of CWD-suspect deer herds. Selective use of this test 
to investigate herds suspected of having subclinical CWD, in 
conjunction with traditional postmortem testing, could pro-
vide valuable information to animal health officials as well 
as reduce the costs associated with postmortem testing.
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